Watchlist Price Alert

NGM Biopharmaceuticals In... (NGM)

NASDAQ: NGM · Real-Time Price · USD

1.54

-0.02 (-1.28%)

At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	58.81M	73.46M	151.79M	147.02M	245.6M	56.92M	25.59M	45.46M
Short-Term Investments	88.37M	198.04M	214.46M	148.14M	98.91M	149.71M	148.09M	184.73M
Long-Term Investments	2.46M	3.95M	1.5M	1.5M	1.87M	n/a	45.15M	12.71M
Other Long-Term Assets	2.94M	4M	7.49M	4.59M	3.81M	7.63M	3.38M	2.41M
Receivables	58K	7.58M	4.95M	6.43M	5.21M	3.67M	n/a	2.77M
Inventory	n/a	1.00	1.00	1.00	1.00	n/a	n/a	n/a
Other Current Assets	9.2M	9.79M	8.08M	6.84M	5.53M	4.25M	1.85M	1.72M
Total Current Assets	156.44M	288.86M	379.28M	308.43M	355.25M	214.56M	175.53M	234.68M
Property-Plant & Equipment	7.03M	10.59M	14.12M	14.53M	19.48M	23.89M	24.87M	27.19M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.42M	18.54M	23.11M	20.62M	25.16M	31.53M	73.41M	42.31M
Total Assets	168.87M	307.4M	402.39M	329.04M	380.4M	246.09M	248.94M	276.99M
Account Payables	2.98M	8.45M	5.25M	9.66M	9.03M	5.78M	1.89M	8.42M
Deferred Revenue	n/a	366K	17.77M	n/a	4.87M	19.02M	21.36M	19.08M
Short-Term Debt	n/a	5.38M	5.08M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	17.1M	33.64M	33.26M	32.92M	25.82M	16.69M	13.64M	10.19M
Total Current Liabilities	20.08M	47.84M	61.35M	42.58M	39.72M	41.49M	36.89M	37.69M
Long-Term Debt	n/a	n/a	5.38M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	149K	n/a	n/a	6.42M	9.97M	13.78M	310.28M	312.82M
Total Long-Term Liabilities	149K	14.2M	5.38M	6.42M	9.97M	17.72M	333.03M	354.36M
Total Liabilities	20.23M	47.84M	66.74M	49M	49.68M	59.21M	369.92M	392.06M
Total Debt	n/a	5.38M	10.46M	n/a	n/a	n/a	n/a	n/a
Common Stock	83K	82K	78K	71K	67K	54K	12K	11K
Retained Earnings	-724.01M	-581.63M	-418.97M	-298.63M	-196.14M	-147.19M	-146.7M	-132.54M
Comprehensive Income	18K	-302K	-129K	4K	25K	-267K	-431K	-102K
Shareholders Equity	148.64M	259.56M	335.65M	280.04M	330.72M	186.88M	-120.98M	-115.06M
Total Investments	90.82M	198.04M	214.46M	148.14M	98.91M	149.71M	193.24M	197.44M